Fosfomycin: A Novel Epoxide Antimicrobial

Video
Conference|ID Week

Evelyn J. Ellis-Grosse, PhD, chief scientific officer of Zavante Therapeutics, explains why Zavante Therapeutic’s fosfomycin is a unique, novel antimicrobial.

Evelyn J. Ellis-Grosse, PhD, chief scientific officer of Zavante Therapeutics, explains why Zavante Therapeutic’s fosfomycin is a novel antimicrobial. She also shares what the drug’s unique mechanism of action is.

Recent Videos
Related Content
CACTUS Study Compares Ceftolozane-Tazobactam vs. Ceftazidime-Avibactam for MDR Pseudomonas

CACTUS Study Compares Ceftolozane-Tazobactam vs. Ceftazidime-Avibactam for MDR Pseudomonas

Sophia Abene;Jason M. Pogue, PharmD
December 20th 2024
Article
From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc
August 1st 2024
Podcast
Long-Acting Lenacapavir Shows Efficacy in Heavily Treatment-Experienced Patients

Long-Acting Lenacapavir Shows Efficacy in Heavily Treatment-Experienced Patients

Sophia Abene
November 11th 2024
Article
From Pathogen to Infectious Disease Diagnosis

From Pathogen to Infectious Disease Diagnosis

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc
July 12th 2024
Podcast
What We Know But Still Have to Learn About Long COVID

What We Know But Still Have to Learn About Long COVID

Sophia Abene;Isabella Ciccone, MPH;Ravindra Ganesh, MD, MBBS, FACP, Dip ABOM;Monica Verduzco-Gutierrez, MD;Svetlana Blitshteyn, MD, FAAN
November 8th 2024
Article
Efficacy of HIV Combination Antiretroviral Medication in Black Individuals

Efficacy of HIV Combination Antiretroviral Medication in Black Individuals

Sophia Abene
November 7th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.